| A review of the pathophysiology and potential biomarkers for peripheral artery disease SM Krishna, JV Moxon, J Golledge International journal of molecular sciences 16 (5), 11294-11322, 2015 | 198 | 2015 |
| Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects JV Moxon, A Parr, TI Emeto, P Walker, PE Norman, J Golledge Current problems in cardiology 35 (10), 512-548, 2010 | 155 | 2010 |
| Animal models of abdominal aortic aneurysm and their role in furthering management of human disease A Trollope, JV Moxon, CS Moran, J Golledge Cardiovascular Pathology 20 (2), 114-123, 2011 | 117 | 2011 |
| Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm C Rush, M Nyara, JV Moxon, A Trollope, B Cullen, J Golledge BMC genomics 10, 1-20, 2009 | 113 | 2009 |
| Meta-analysis of peak wall stress in ruptured, symptomatic and intact abdominal aortic aneurysms S Khosla, DR Morris, JV Moxon, PJ Walker, TC Gasser, J Golledge Journal of British Surgery 101 (11), 1350-1357, 2014 | 107 | 2014 |
| Association between metformin prescription and growth rates of abdominal aortic aneurysms J Golledge, J Moxon, J Pinchbeck, G Anderson, S Rowbotham, J Jenkins, ... Journal of British Surgery 104 (11), 1486-1493, 2017 | 94 | 2017 |
| Oxidative stress and abdominal aortic aneurysm: potential treatment targets TI Emeto, JV Moxon, M Au, J Golledge Clinical science 130 (5), 301-315, 2016 | 91 | 2016 |
| Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model SM Krishna, SW Seto, JV Moxon, C Rush, PJ Walker, PE Norman, ... The American journal of pathology 181 (2), 706-718, 2012 | 90 | 2012 |
| Lack of an effective drug therapy for abdominal aortic aneurysm J Golledge, JV Moxon, TP Singh, MJ Bown, K Mani, A Wanhainen Journal of internal medicine 288 (1), 6-22, 2020 | 83 | 2020 |
| Body mass index is inversely associated with mortality in patients with peripheral vascular disease J Golledge, O Cronin, V Iyer, B Bradshaw, JV Moxon, MA Cunningham Atherosclerosis 229 (2), 549-555, 2013 | 78 | 2013 |
| Systematic review and meta-analysis of the association between C-reactive protein and major cardiovascular events in patients with peripheral artery disease TP Singh, DR Morris, S Smith, JV Moxon, J Golledge European Journal of Vascular and Endovascular Surgery 54 (2), 220-233, 2017 | 73 | 2017 |
| Circulating microRNAs as biomarkers for acute ischemic stroke: a systematic review B Dewdney, A Trollope, J Moxon, DT Manapurathe, E Biros, J Golledge Journal of Stroke and Cerebrovascular Diseases 27 (3), 522-530, 2018 | 71 | 2018 |
| The Sigma Class Glutathione Transferase from the Liver Fluke Fasciola hepatica EJ LaCourse, S Perally, RM Morphew, JV Moxon, M Prescott, DJ Dowling, ... PLoS neglected tropical diseases 6 (5), e1666, 2012 | 71 | 2012 |
| Proteomic analysis of glutathione transferases from the liver fluke parasite, Fasciola hepatica G Chemale, R Morphew, JV Moxon, AL Morassuti, EJ LaCourse, J Barrett, ... Proteomics 6 (23), 6263-6273, 2006 | 71 | 2006 |
| Association of lower extremity performance with cardiovascular and all‐cause mortality in patients with peripheral artery disease: a systematic review and meta‐analysis DR Morris, AJ Rodriguez, JV Moxon, MA Cunningham, MM McDermott, ... Journal of the American Heart Association 3 (4), e001105, 2014 | 67 | 2014 |
| Resveratrol inhibits growth of experimental abdominal aortic aneurysm associated with upregulation of angiotensin-converting enzyme 2 CS Moran, E Biros, SM Krishna, Y Wang, C Tikellis, SK Morton, JV Moxon, ... Arteriosclerosis, thrombosis, and vascular biology 37 (11), 2195-2203, 2017 | 59 | 2017 |
| Matricellular protein CCN3 mitigates abdominal aortic aneurysm C Zhang, D Van Der Voort, H Shi, R Zhang, Y Qing, S Hiraoka, ... The Journal of clinical investigation 126 (4), 1282-1299, 2016 | 53 | 2016 |
| The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: A meta-analysis of observational studies V Nsengiyumva, ME Fernando, JV Moxon, SM Krishna, J Pinchbeck, ... Atherosclerosis 243 (2), 645-651, 2015 | 53 | 2015 |
| Everolimus limits aortic aneurysm in the apolipoprotein E–deficient mouse by downregulating CC chemokine receptor 2 positive monocytes CS Moran, RJ Jose, JV Moxon, A Roomberg, PE Norman, C Rush, ... Arteriosclerosis, thrombosis, and vascular biology 33 (4), 814-821, 2013 | 52 | 2013 |
| Meta-analysis of the association between transforming growth factor-beta polymorphisms and complications of coronary heart disease DR Morris, JV Moxon, E Biros, SM Krishna, J Golledge Plos one 7 (5), e37878, 2012 | 49 | 2012 |
Smriti Murali KrishnaUniversity of MelbourneVerified email at unimelb.edu.au
